Prostate adenocarcinoma (PRAD): LRFN4 was associated with T cells, CD8+ T cells, cytotoxic lymphocytes, B lineage cells, NK cells, myeloid dendritic cells, neutrophils, endothelial cells, and fibroblasts. Here, LRFN4 is linked to prostate adenocarcinoma.